Aqr Capital Management LLC Cytosorbents Corp Transaction History

Aqr Capital Management LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.88 - $4.23 $116,458 - $171,048	-40,437 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$4.05 - $8.11 $93,247 - $186,724	23,024 Added 132.22%	40,437 $169,000
Q3 2021 Nov 15, 2021	SELL	$7.0 - $9.71 $472,598 - $655,560	-67,514 Reduced 79.5%	17,413 $141,000
Q2 2021 Aug 16, 2021	SELL	$7.55 - $9.42 $270,735 - $337,791	-35,859 Reduced 29.69%	84,927 $641,000
Q1 2021 May 17, 2021	SELL	$8.23 - $11.48 $13,480 - $18,804	-1,638 Reduced 1.34%	120,786 $1.05 Million
Q4 2020 Feb 16, 2021	SELL	$7.65 - $8.98 $50,627 - $59,429	-6,618 Reduced 5.13%	122,424 $976,000
Q3 2020 Nov 16, 2020	BUY	$7.37 - $11.54 $951,039 - $1.49 Million	129,042 New	129,042 $1.03 Million
Q4 2019 Feb 14, 2020	SELL	$3.61 - $5.22 $55,958 - $80,915	-15,501 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$4.33 - $7.63 $47,876 - $84,364	-11,057 Reduced 41.63%	15,501 $78,000
Q2 2019 Aug 14, 2019	SELL	$5.92 - $7.78 $36,579 - $48,072	-6,179 Reduced 18.87%	26,558 $176,000
Q2 2018 Aug 14, 2018	BUY	$6.9 - $12.35 $225,885 - $404,301	32,737 New	32,737 $373,000

16.9M

10.1K

500

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $51.9M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.